Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
September 26, 2024 09:05 ET
|
Longeveron
Longeveron to attend Cell & Gene Meeting on the Mesa to highlight its cellular therapy program in Alzheimer's disease and CDMO facilities and services.
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
June 03, 2024 09:00 ET
|
Longeveron
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
Stem Cell Manufacturing Market Worth USD 26.6 billion, Growing At 9.2% CAGR by 2033 - Report By Transparency Market Research, Inc.
March 07, 2024 04:59 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 07, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global stem cell manufacturing market is estimated to flourish at a CAGR of 9.2% from...
Global Stem Cell Manufacturing Market 2023-2028: Key Players Thermo Fisher Scientific, Merck KGaA, Lonza Group and Danaher Corporation Take the Lead
August 31, 2023 07:28 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue &...
Stem Cell Manufacturing Market to Hit USD 26.6 Bn Valuation by 2033 Due to Rising Demand for Cell Treatments | TMR
March 21, 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 22, 2023 (GLOBE NEWSWIRE) -- According to the latest study by Transparency Market Research, the global stem cell manufacturing market size was worth USD...
Outlook on the $20.7 Billion Stem Cell Manufacturing Global Market to 2030: Featuring Lonza, Medipost, Merck, Miltenyi Biotec and Osiris Therapeutics Among Others
February 28, 2023 13:23 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Stem Cell Manufacturing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell...
Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Management, Personalized Medicine, and Genome Testing Applications Bolsters Growth
October 11, 2022 08:28 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Cell Therapy Manufacturing Market is expected to reach a valuation of US$ 13.9 Billion by the end of 2032, at a CAGR of 14.2% from 2022-2032 | Future Market Insights, Inc.
September 05, 2022 09:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 05, 2022 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and...
Stem Cell Manufacturing Market Worth USD 21 Billion by 2030 at 11.2% CAGR - Report by Market Research Future (MRFR)
June 30, 2022 06:27 ET
|
Market Research Future
New York, USA, June 30, 2022 (GLOBE NEWSWIRE) -- Stem Cell Manufacturing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Stem Cell...
Stem Cell Manufacturing Market Size to Reach USD 28.85 Billion in 2028: Reports and Data
June 09, 2021 03:06 ET
|
Reports and Data
New York, June 09, 2021 (GLOBE NEWSWIRE) -- Major factors driving market revenue growth include increasing use of stem cells to treat various diseases, rising stem cell-based research activities,...